You are here: Industry Insights > AstraZeneca

News List

Bevespi Aerosphere demonstrates statistically significant improvement in lung function in patients w worldpharmanews
September 26, 2017
Dr. Colin Reisner, Head of Respiratory, Global Medicines Development at AstraZeneca, said: "These positive results add to the strong established efficacy and safety profile of Bevespi Aerosphere in the treatment of patients with COPD.
GSK joins AstraZeneca and Labcyte to develop acoustic mass spectrometry pharmaceufical-technology
September 25, 2017
GSK has joined forces with AstraZeneca and Labcyte to combine acoustic liquid dispensing technology with mass spectrometry (MS) for use in high throughput small molecule screening and other drug discovery applications.
AstraZeneca, Aspen Enter Agreement for Remaining Rights to Anaesthetics Medicines americanpharmaceuticacreview
September 15, 2017
The new, additional agreement is expected to close in the fourth quarter of 2017, subject to customary closing conditions and regulatory clearances.
AstraZeneca’s Forxiga displays potential in type 1 diabetes pharmafile
September 15, 2017
Forxiga is AstraZeneca’s treatment for those living with type 2 diabetes but the results from a new trial have found that the pill may have benefits in harder to treat type 1 diabetes.
AstraZeneca’s Global Medicines Development group to expand in Bengaluru expressbpd
September 13, 2017
The types of roles include: regulatory professionals, regulatory project managers and leaders and physicians
AstraZeneca presents new results identifying severe asthma patients who would benefit most from benr worldpharmanews
September 13, 2017
AstraZeneca has announced results from a subgroup analysis of the SIROCCO and CALIMA Phase III trials.
AstraZeneca's Tagrisso beats standard of care in halting NSCLC pharmafile
September 12, 2017
AstraZeneca has revealed new data at the European Society of Medical Oncology on the efficacy of Tagrisso (osimertinib) in the first-line treatment of epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer in adult patients.
AstraZeneca and Amgen severe asthma drug is 'one to watch' after phase 2 win fiercebiotech
September 08, 2017
A first-in-class therapy developed by AstraZeneca and Amgen looks like a strong treatment candidate for severe uncontrolled asthma, according to a respiratory specialist.
FDA clears Adherium’s usage tracker for AstraZeneca inhaler fiercebiotech
September 05, 2017
Australian smart inhaler maker Adherium has scored an FDA nod for its SmartTouch device, for use with AstraZeneca’s Symbicort aerosol inhalers.
AstraZeneca, Takeda sign $400m deal for Parkinson’s therapy pharmatimes
August 31, 2017
AstraZeneca and Takeda are to jointly develop and commercialise an experimental therapy for Parkinson’s disease

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page